Variants in mitochondrial amidoxime reducing component 1 and hydroxysteroid 17-beta dehydrogenase 13 reduce severity of nonalcoholic fatty liver disease in children and suppress fibrotic pathways through distinct mechanisms. (2022)

First Author: Hudert C
Attributed to:  The validation of biomarkers of metabolic efficacy in infant nutrition funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.17863/cam.83448

Publication URI: https://www.repository.cam.ac.uk/handle/1810/336017

Type: Journal Article/Review